OMC

OMC Operating Cash Flow (Statement)

$2.58BTTM · USD

Period ending:

OMC FY Cash from OperationsUSD
OMC FY Cash from Operations1989-12-31: $124.50M1990-12-31: $111.60M1991-12-31: $143.60M1992-12-31: $181.70M1993-12-31: $209.20M1994-12-31: $339.20M1995-12-31: $226.60M1996-12-31: $494.00M1997-12-31: $533.80M1998-12-31: $471.40M1999-12-31: $901.00M2000-12-31: $685.88M2001-12-31: $775.56M2002-12-31: $1.00B2003-12-31: $1.05B2004-12-31: $1.29B2005-12-31: $991.20M2006-12-31: $1.74B2007-12-31: $1.60B2008-12-31: $1.39B2009-12-31: $1.73B2010-12-31: $1.49B2011-12-31: $1.32B2012-12-31: $1.45B2013-12-31: $1.81B2014-12-31: $1.48B2015-12-31: $2.17B2016-12-31: $1.93B2017-12-31: $2.02B2018-12-31: $1.72B2019-12-31: $1.86B2020-12-31: $1.72B2021-12-31: $1.95B2022-12-31: $926.50M2023-12-31: $1.42B2024-12-31: $1.73B2025-12-31: $2.94B$2.94B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

OMC operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Omnicom Group Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
2,938,200,000
1,733,500,000
1,421,900,000
926,500,000
1,945,400,000
1,724,600,000
1,856,000,000
1,722,300,000
2,023,900,000
1,931,200,000
2,172,300,000
1,476,500,000
1,809,000,000
1,451,300,000
1,315,300,000
1,488,000,000
1,731,600,000
1,394,200,000
1,599,300,000
1,741,200,000
991,200,000
1,287,600,000
1,054,242,000
1,000,601,000
775,560,000
685,879,000
901,000,000
471,400,000
533,800,000
494,000,000
226,600,000
339,200,000
209,200,000
181,700,000
143,600,000
111,600,000
124,500,000

Compare operating cash flow (statement)

All OMC financial metrics · OMC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.